Your browser doesn't support javascript.
loading
Cost-effectiveness Analysis on Different Doses of Methylprednisolone Treatment Regimes on Postopera-tive Traumatic Reaction in Patietents of Cervical Spondylotic Myelopathy / 中国药房
China Pharmacy ; (12)2001.
Article in Chinese | WPRIM | ID: wpr-524667
ABSTRACT

OBJECTIVE:

To evaluate the economic effects of different doses of methylprednisolone treatment regimes on traumatic reaction in patients with cervical spondylotic myelopathy after anterior decompressive operation.

METHODS:

56cervical spondylotic myelopathy cases who have been subjected to anterior decompressive operation were chosen to be the sub-jects.The56cases were divided into3groups and treated with different dosage of methylprednisolone,the initial dose for group A(18cases,low dose group)was80mg;the initial dose for group B(21cases,medium dose group)was600mg and that for group C(17cases,large dose group)was1000mg,the improvement of clinical symptom of each group was observed re-spectively and the cost-effectivenesses of the three groups were compared.

RESULTS:

The costs of the A,B,C groups were990.00,1339.10and1886.70yuan respectively;the effectiveness rates(E)of the A,B,C groups were5.56%,14.29%and35.29%respectively;The costs for each unit of obvious effectiveness(C/E)of the A,B,C groups were178.06,93.71and53.46yuan respectively;On the basis of group A,the needed costs of group B and C were39.99and30.16yuan respectively for each obvious effectiveness unit increase(?C/?E).

CONCLUSION:

Compared with group A and B,the effectiveness rates of group C had a bigger increase while the needed cost for each unit of obvious effectiveness was the lowest,therefore,the dose regimen of group C is more rational.

Full text: Available Index: WPRIM (Western Pacific) Type of study: Health economic evaluation Language: Chinese Journal: China Pharmacy Year: 2001 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Type of study: Health economic evaluation Language: Chinese Journal: China Pharmacy Year: 2001 Type: Article